Matches in Nanopublications for { ?s ?p "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP279042.RAOGsSlBsci7gf83axszkA__uyZUb9qEP_3gE0fpVCVmw130_assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279042.RAOGsSlBsci7gf83axszkA__uyZUb9qEP_3gE0fpVCVmw130_provenance.
- assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP718338.RApy2KiLrH_acDl-VIe3pO21PlHEQHW1auLJhO7Ze10YY130_assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718338.RApy2KiLrH_acDl-VIe3pO21PlHEQHW1auLJhO7Ze10YY130_provenance.
- NP718364.RAq44CSmHMYtrF7VpjpcrpoYHepTGiMIAPVcDcv6AwI1o130_assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718364.RAq44CSmHMYtrF7VpjpcrpoYHepTGiMIAPVcDcv6AwI1o130_provenance.
- NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418601.RAuQu24oSu7Es3D4dEwCZ7i3AQfFu_NjrDRSwIi1Kg8b4130_provenance.
- NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418603.RApi5y2I8dFIsF0_O3Xl3TZJyt-nnzI18cg_tK-7GbCq0130_provenance.
- NP418604.RAhKSnUXAjwvAfyOsFpWzCkX0Ul7SWAzUO70LzjxLxU2A130_assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418604.RAhKSnUXAjwvAfyOsFpWzCkX0Ul7SWAzUO70LzjxLxU2A130_provenance.
- NP718412.RAGWCig9fWorPUOb48kUn_m9dY7V0OjKRtXFOkfSgQ5_8130_assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718412.RAGWCig9fWorPUOb48kUn_m9dY7V0OjKRtXFOkfSgQ5_8130_provenance.
- NP718322.RA0Y_ZQKKdgbyUzjXwJowT1PHIL42yR5PbvN2uA758bmQ130_assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718322.RA0Y_ZQKKdgbyUzjXwJowT1PHIL42yR5PbvN2uA758bmQ130_provenance.
- NP418602.RA0_jkFzmorowDU_W4mF4p8X_0ZD2tCH0O8IiKDgpeauA130_assertion description "[In human insulinoma (CM) cells, in human pancreatic carcinoid (BON) cells and in NE tumour cells of the gut (STC-1), gefitinib induced a time- and dose-dependent growth inhibition by almost 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418602.RA0_jkFzmorowDU_W4mF4p8X_0ZD2tCH0O8IiKDgpeauA130_provenance.